Governance

Mr. Foust serves as President and Chief Executive Officer and as a member of the Board of Directors of STAAR Surgical, roles to which he was appointed in August 2026. He joined STAAR in April 2023 as Chief Operating Officer, was appointed President and Chief Operating Officer in March 2025, and named Interim Co-Chief Executive Officer in February 2026. In these roles, Mr. Foust was responsible for research and development, global sales, marketing, manufacturing, and operations, leading the Company through a successful operational reset and return to profitable growth. Previously, he held senior leadership roles at Johnson & Johnson, including Worldwide President of Surgical Vision and Worldwide President of Mentor, along with earlier roles at DePuy Synthes, Aventis Pharmaceuticals and Roche Pharmaceuticals.

Mr. Foust serves on a variety of boards and advisory councils including the Ophthalmology Foundation, Gavin Herbert Eye Institute, Octane, ASCRS Industry Relations, AECOS North America, and the Board of Visitors for the University of Alabama. He holds both a master's degree and a bachelor's degree from the University of Alabama.

Ms. Andrews serves as Executive Vice President and Chief Financial Officer, roles to which she was appointed in August 2026.  She rejoined STAAR in March 2025 as Interim Chief Financial Officer and was appointed Chief Financial Officer in June 2025. As CFO, Ms. Andrews oversees STAAR’s finance, accounting, internal audit, information technology, and investor relations functions. She brings extensive financial and operational experience to the role, having previously held a variety of accounting and finance leadership positions at STAAR from 1995 until her retirement in 2020. During that time, she served twice as Chief Financial Officer—from 2005 to 2013 and from September 2017 through June 2020.

Since April 2014, Ms. Andrews has served on the Board of Directors of Lineage Cell Therapeutics, a clinical-stage biotechnology company focused on regenerative medicine. She currently serves as Chair of its Audit Committee and previously served as Chair of its Compensation Committee.

Earlier in her career, Ms. Andrews was a Senior Accountant at KPMG from 1991 to 1994. She holds a bachelor’s degree from California State University, San Bernardino.

Dr. Barnes joined STAAR in October 2017 as Chief Medical Officer. Dr. Barnes joined STAAR after a distinguished 30-year career with the military, retiring at the rank of Colonel in September 2017. From 2004 to 2017, Dr. Barnes served as Chief of Ophthalmology Services, Womack Army Medical Center, Fort Bragg, North Carolina. Soon after he joined Womack, he was asked to serve as the theater ophthalmology consultant and surgeon in Iraq and Afghanistan during 2005. In 2008, Colonel Barnes was awarded the Army Surgeon General's A designator, similar to the level of professor at a civilian institution. Dr. Barnes began his medical career in 1986 as a research assistant in the Department of Genetics, Harvard Medical School/Children's Hospital in Boston and in 1991 became a general surgery intern at William Beaumont Army Medical Center. He went on to become a Special Forces (“Green Beret”) Battalion and Group Surgeon as well as the Deputy Surgeon for the US Army Special Operations Command. He completed an ophthalmology residency at the Wilford Hall/Brooke Army Medical Center in San Antonio, Texas in 1998. Colonel Barnes held numerous ophthalmology positions at a number of military bases and was asked to serve as the Deputy Commander for Clinical Services for all combat trauma, medical, veterinary, and dental care in Afghanistan during a 13-month deployment in 2011 to 2012. Dr. Barnes has given more than 200 presentations and lectures as well as led over 30 ophthalmology or refractive surgery research projects. He has been awarded Speaker of the Day at the Royal Hawaiian Eye Meeting ten times as well as numerous other awards and honors at industry meetings. In addition to earning his Bachelor of Arts degree from Wheaton College, and his doctorate degree from Northwestern University Medical School in Chicago, Dr. Barnes' post-doctoral training includes a Cornea Fellowship at the Massachusetts Eye and Ear Infirmary/Harvard Medical School in Boston.

Dr. Michna joined STAAR in April 2023 as Chief Clinical, Regulatory and Medical Affairs Officer. Previously, Dr. Michna served as Chief Global Clinical, Medical and Regulatory Affairs Officer of AcuFocus, Inc. from April 2018 until April 2023. AcuFocus was acquired by Bausch & Lomb in January 2023. Prior to AcuFocus, Dr. Michna served as Chief Clinical Officer at Presbia, PLC. From 2012 to 2017, Dr. Michna led clinical development for many premium intraocular lens and other surgical device technologies supporting the Alcon Surgical franchise. Dr. Michna’s industry career began as a Vision Scientist at VISTAKON®, a division of Johnson & Johnson Vision from 2008-2012, which she joined following an academic Research Fellowship with the Vision Research Group at McGill University’s Department of Ophthalmology from 2005-2008. She holds a Doctor of Philosophy degree in optical physics and a bachelor’s degree from the University of Melbourne, Australia.

Mr. Filip De Keersmaecker joined STAAR in June 2025 as Senior Vice President End-to-End Supply Chain. Prior to joining STAAR, Filip served as a Senior Advisor for McKinsey and several healthcare companies. He operated from 2023-2025 in executive roles within Johnson & Johnson across the Consumer, Innovative Medicine and Medical Technology businesses. During his time in MedTech, he led the regional supply chains as well as the strategic programs from 2021-2023. From 2019 to 2021, he operated as the Global Vice President Supply Chain for the Cardiovascular and Specialty Solutions business, leading more than 6,500 employees across multiple manufacturing locations worldwide. From 2015-2017, he was a member of the Strategy and Deployment Group at J&J to drive transformational change. At Innovative Medicine from 2011-2015, he was the Vice President Product Management and in charge of the APAC E2E Supply Chain with manufacturing locations across the region. During his time at Consumer, he led the EMEA E2E Consumer Supply Chain from 2007-2011 with >4,500 employees across the region. Filip serves as a Board member at H. Essers, a family-owned business with a consolidated revenue of >$1 Bn, providing personalized and integrated solutions for sustainable transport and logistics. Filip holds a bachelor’s and master’s degrees in military and social sciences, a bachelor’s in economics and master’s degrees in transport, logistics and maritime management.

Ms. Determann joined STAAR in August 2023 as the Associate General Counsel, was appointed as Deputy General Counsel, Chief Compliance and Privacy Officer in 2025, and Sr. Deputy General Counsel in April 2026. In this role, Ms. Determann leads STAAR's global legal, compliance and privacy functions, as well as corporate governance and risk management. Prior to joining STAAR, she had decades of leadership experience at established health technology companies, including Genomic Health (NASDAQ: GHDX), Adaptive Biotechnologies (NASDAQ: ADPT), and Nevro Corp. (NYSE:NVRO), as well as startups in metagenomic sequencing and digital health. In these roles, she drove complex business development initiatives, built IP portfolios, created successful privacy and compliance programs, and aligned corporate commercial strategies to evolving global regulatory landscapes. Ms. Determann also served as a patent and litigation attorney in private practice. She holds a JD from the University of San Francisco, bachelor's degrees in political science from UCLA and molecular biology and biochemistry from Santa Clara University and is a Certified Information Privacy Professional (CIPP/E, CIPM, CHPC).